Biofrontera (BFRI) Net Income Growth (1y) (2021 - 2025)
Biofrontera (BFRI) Net Income Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 68.18% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -384.49% |
| 5 | United Therapeutics | 23.01 Bn | 20.85 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.41 Bn | 18.61 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | 2,405.06% |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | -14.93% |
| 10 | Biofrontera | 10.73 Mn | 4.32 Mn | 14.09 Mn | 663.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 663.90% |
| Sep 30, 2025 | -17.29% |
| Jun 30, 2025 | -1,971.60% |
| Mar 31, 2025 | 59.73% |
| Dec 31, 2024 | -139.59% |
| Sep 30, 2024 | 10.61% |
| Jun 30, 2024 | 97.39% |
| Mar 31, 2024 | -39.57% |
| Dec 31, 2023 | 226.61% |
| Sep 30, 2023 | -147.16% |
| Jun 30, 2023 | -1,057.29% |
| Mar 31, 2023 | -234.47% |
| Dec 31, 2022 | 80.80% |
| Sep 30, 2022 | 83.97% |
| Jun 30, 2022 | 76.78% |
| Mar 31, 2022 | 257.36% |
| Dec 31, 2021 | -7,698.39% |
| Sep 30, 2021 | -436.42% |